Search results
Does Intercept (ICPT) Have the Potential to Rally 52.08% as Wall Street Analysts Expect?
Zacks via Yahoo Finance· 1 year agoThe average of price targets set by Wall Street analysts indicates a potential upside of 52.1% in...
Intercept Pharmaceuticals (ICPT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Zacks via Yahoo Finance· 10 months agoIntercept (ICPT) possesses the right combination of the two key ingredients for a likely earnings...
Biotech Stock Roundup: ICPT Up on Buyout Deal, IMVT & PLRX Gain on Study Data
Zacks via Yahoo Finance· 8 months agoIt was a busy week for the biotech sector, with a lot of important regulatory and pipeline updates....
Intercept Pharmaceuticals (NASDAQ:ICPT) shareholders have endured a 83% loss from investing in the...
Simply Wall St. via Yahoo Finance· 7 months agoIt is a pleasure to report that the Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) is up 67% in the...
Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) down to US$672m market cap, but institutional owners...
Simply Wall St. via Yahoo Finance· 1 year agoKey Insights Institutions' substantial holdings in Intercept Pharmaceuticals implies that they have...
Shareholders in Intercept Pharmaceuticals (NASDAQ:ICPT) are in the red if they invested three years...
Simply Wall St. via Yahoo Finance· 2 years agoIntercept Pharmaceuticals, Inc. (NASDAQ:ICPT) shareholders should be happy to see the share price up...
Institutional owners may take dramatic actions as Intercept Pharmaceuticals, Inc.'s (NASDAQ:ICPT)...
Simply Wall St. via Yahoo Finance· 2 years agoEvery investor in Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) should be aware of the most powerful...
Intercept (ICPT) Earnings and Sales Miss Estimates in Q2
Zacks via Yahoo Finance· 2 years agoIntercept Pharmaceuticals, Inc. ICPT incurred a loss of 68 cents per share in second-quarter 2022,...
Intercept Pharmaceuticals, Inc.'s (NASDAQ:ICPT) Low P/S No Reason For Excitement
Simply Wall St. via Yahoo Finance· 1 year agoWith a price-to-sales (or "P/S") ratio of 2.3x Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) may be...
Intercept Pharmaceuticals (ICPT) Reports Q2 Loss, Beats Revenue Estimates (Revised)
Zacks via Yahoo Finance· 2 years agoIntercept (ICPT) delivered earnings and revenue surprises of -28.30% and +5.86%, respectively, for...